Published in Arch Intern Med on August 01, 1967
Screening for occult lung cancer. Can Med Assoc J (1983) 0.77
Computed tomography of lung parenchyma. Bull N Y Acad Med (1986) 0.75
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS (1998) 8.88
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet (1999) 7.08
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis (2000) 5.23
Adverse effects of antiretroviral therapy. Lancet (2000) 4.84
Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet (1985) 4.83
Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38
The 2010 Royal Australasian College of Physicians' policy statement 'Circumcision of infant males' is not evidence based. Intern Med J (2012) 4.15
A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med (1995) 3.89
Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol (1996) 3.48
Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet (1985) 3.33
Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS (1999) 3.28
Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet (1998) 3.22
Primary HIV infection: host responses and intervention strategies. AIDS (1991) 2.80
Prevalence of flat lesions in a large screening population and their role in colonoscopy quality improvement. Endoscopy (2013) 2.72
Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med (1992) 2.65
Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet (1992) 2.60
Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis (1996) 2.44
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Lancet (1998) 2.43
CD8+ lymphocyte responses to antiretroviral therapy of HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 2.23
Identification of the receptor for antigen and major histocompatibility complex on human inducer T lymphocytes. Science (1983) 2.21
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS (2001) 2.17
HIV disease progression in Australia in the time of combination antiretroviral therapies. Med J Aust (1998) 2.16
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia. Nat Med (2001) 2.14
The pancreas as a site of granulomatous inflammation in Crohn's disease. Gastroenterology (1995) 2.14
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals. AIDS (2001) 2.03
Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. Med J Aust (1989) 2.02
Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease. J Infect Dis (2000) 1.91
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
Role of Aspergillus amylase in baker's asthma. Lancet (1986) 1.87
CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS (1991) 1.85
The role of initial AIDS-defining illness in survival following AIDS. AIDS (1995) 1.82
Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J Immunol (1995) 1.79
Acquired immunodeficiency without evidence of HIV infection: national retrospective survey. BMJ (1994) 1.78
Ribavirin: a role in HIV infection? J Acquir Immune Defic Syndr (1990) 1.74
Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. J Infect Dis (1999) 1.70
The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis (1991) 1.69
ICRP Publication 111 - Application of the Commission's recommendations to the protection of people living in long-term contaminated areas after a nuclear accident or a radiation emergency. Ann ICRP (2009) 1.63
A special form of segmental pancreatitis: "groove pancreatitis". Hepatogastroenterology (1982) 1.62
Lung cancer in chloromethyl methyl ether workers. N Engl J Med (1973) 1.55
Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood (1993) 1.54
Fetal heart rate as a predictor of fetal distress. A report from the collaborative project. Obstet Gynecol (1968) 1.51
Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room. AIDS (1996) 1.46
Mortality of a cohort exposed to chrysotile asbestos. J Occup Med (1977) 1.44
The neurological features of early and 'latent' human immunodeficiency virus infection. Aust N Z J Med (1989) 1.42
Syringe HIV seroprevalence and behavioural and demographic characteristics of intravenous drug users in Sydney, Australia, 1987. AIDS (1988) 1.41
Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group. J Infect Dis (1998) 1.41
Bile acid malabsorption in HIV infected patients with chronic diarrhoea. Aust N Z J Med (1996) 1.40
Survival of patients with the acquired immunodeficiency syndrome in Australia. Med J Aust (1989) 1.39
[Hyponatremic coma as the first symptom of a small cell bronchial carcinoma]. Dtsch Med Wochenschr (1994) 1.39
Clinical outcome two years after implantation of a transjugular intrahepatic portosystemic shunt for recurrent variceal bleeding. Eur J Gastroenterol Hepatol (1997) 1.39
HIV and hepatitis C coinfection within the CAESAR study. HIV Med (2004) 1.39
Cigarette smoke, asbestos, and small irregular opacities. Am Rev Respir Dis (1984) 1.38
If it's the virus, why aren't we measuring it? Med J Aust (1995) 1.38
Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet (1987) 1.37
The Philadelphia Pulmonary Neoplasm Research Project. The risk of lung cancer in relation to symptoms and roentgenographic abnormalities. Environ Res (1977) 1.35
Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus. Virology (1989) 1.35
Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol (1994) 1.34
Risk of lung cancer according to histologic type and cigarette dosage. JAMA (1972) 1.34
HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med (2003) 1.34
Smoking and cancer: a rebuttal. Am J Public Health (1975) 1.34
Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group. J Infect Dis (1997) 1.33
Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr (2001) 1.32
Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus. J Immunol (2000) 1.32
Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor. Lancet (1997) 1.30
Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor. N Engl J Med (1998) 1.29
Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Med (2007) 1.29
A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology (1991) 1.29
Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis (1990) 1.26
ELISPOT assay for detection of peptide specific interferon-gamma secreting cells in rhesus macaques. J Immunol Methods (2001) 1.24
Is curable lung cancer detected by semiannual screening? JAMA (1973) 1.23
HIV infection of rectal mucosa. Lancet (1988) 1.22
Cigarette smoking and diffuse pulmonary fibrosis. Am Rev Respir Dis (1969) 1.20
Two-dimensional polyacrylamide gel electrophoresis with immobilized pH gradients in the first dimension (IPG-Dalt): the state of the art and the controversy of vertical versus horizontal systems. Electrophoresis (1995) 1.20
B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS (2000) 1.20
Peripheral measurable bronchogenic carcinoma. Growth rate and period of risk after therapy. Am Rev Respir Dis (1971) 1.20
Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents. J Nutr (2001) 1.20
The Apgar score as an index of infant morbidity. A report from the collaborative study of cerebral palsy. Dev Med Child Neurol (1966) 1.19
Cigarette smoking, asbestos, and pulmonary fibrosis. Am Rev Respir Dis (1971) 1.19
Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship. Clin Infect Dis (1998) 1.18
Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy. HIV Med (2006) 1.18
Human cytotoxic T cell clones directed at autologous virus-transformed targets: further evidence for linkage of genetic restriction to T4 and T8 surface glycoproteins. J Immunol (1983) 1.18
Antibody response to human immunodeficiency virus after primary infection. J Infect Dis (1987) 1.17
Behcet's syndrome: clinical, immunological and therapeutic evaluation of 17 patients. Aust N Z J Med (1974) 1.17
Quinolinic acid production is related to macrophage tropic isolates of HIV-1. J Neurovirol (1995) 1.17
Detection and analysis of xenon isotopes for the comprehensive nuclear-test-ban treaty international monitoring system. J Environ Radioact (2002) 1.17
Gastrointestinal viral infections in homosexual men who were symptomatic and seropositive for human immunodeficiency virus. J Infect Dis (1988) 1.15
Baking additives as new allergens in baker's asthma. Respiration (1988) 1.14
Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations. J Immunol (1983) 1.14
Recent developments in two-dimensional gel electrophoresis with immobilized pH gradients: wide pH gradients up to pH 12, longer separation distances and simplified procedures. Electrophoresis (1999) 1.14